Trials / Withdrawn
WithdrawnNCT04317924
Pneumostasis With Use of Bio-absorbable Mesh and Fibrin Sealant in Lung Resection
Use of Polyglycolic Acid Felt for Air-leak Prevention After Lung Resection
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Boston Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prolonged air leak, defined as air leak present 5 days after lung resection, is one of the most common complications after lung resection. This leads to patient discomfort (as the chest tube has to stay in place while air leak is present), prolonged stay, and increased cost. NeoVeil is a bioabsorbable glycolic acid which has been used in Japan and other Asian countries for air leak prevention after lung resections. NeoVeil is impregnated with fibrin sealant materials and is placed on the lung surface at the time of operation. It then acts as a scaffold on resected area which is prone to air leak. This randomized clinical trial will be the first in the United States to test its efficacy for air leak prevention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polyglycolic acid felt | Neoveil is a polyglycolic acid felt that has been shown to decrease the incidence of prolonged air leak after lung resection in Japan. |
| OTHER | Standard of care | Standard of care after air leak post lung resection |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2020-03-23
- Last updated
- 2020-08-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04317924. Inclusion in this directory is not an endorsement.